Skip to main content
OpenTrials
Completed

NCT Number: NCT01100411

Changes in Invitro and ex Vivo Lens Metrology With Daily Wear Contact Lenses

The purpose of this study is to evaluate changes in contact lens geometry after lens wear

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Institute for Eye Research

Sydney, New South Wales, 2052, Australia

About this study

The purpose of this study is to evaluate changes invitro and ex vivo in contact lens geometry in daily lens wear

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • • Able to read and comprehend English and give informed consent as demonstrated by signing a record of informed consent;
  • Be at least 18 years old;
  • Willing to comply with the wearing and clinical trial visit schedule as directed by the investigator;
  • Have ocular health findings considered to be "normal" and which would not prevent the participant from safely wearing contact lenses;
  • Has vision correctable to at least 6/12 (20/40) or better at distance in each eye with contact lenses;
  • Be experienced at wearing contact lenses.

Exclusion criteria

  • • Any pre-existing ocular irritation, injury or condition (including keratoconus and herpes keratitis) of the cornea, conjunctiva or eyelids that would preclude contact lens fitting and safe wearing of contact lenses;
  • Any systemic disease that adversely affects ocular health
  • An active corneal infection or any active ocular disease that would affect wearing of contact lenses;
  • Use of any topical ocular medication during trial with the exception of saline drops ;
  • Use of or a need for any systemic medication or topical medications which may alter normal ocular findings/are known to affect a participant's ocular health/physiology or contact lens performance
  • Eye surgery within 12 weeks immediately prior to enrolment for this trial;
  • Previous corneal refractive surgery;
  • Contraindications to contact lens wear;
  • Participated or currently enrolled in another clinical trial that may have affected vision or ocular physiology within the previous 2 weeks;
  • Be pregnant (formal testing of pregnancy is not required. A participant's verbal report is sufficient);
  • Worn soft contact lenses 2 calendar days or rigid gas permeable/ orthokeratology lenses 7 calendar days prior.

Treatment and study plan

Air Optix Aqua

Device

Contact lens material: Lotrafilcon A

Other names: Air Optix

Biofinity

Device

Contact lens material: Comfilcon A

Other names: CV Biofininty

Proclear

Device

Contact lens material: Omafilcon A

Other names: Proclear Compatibles

Acuvue Oasys

Device

Contact lens material: Senofilcon A

Other names: Oasys

Acuvue 2

Device

Contact lens material: Etafilcon A

Other names: AV 2

Purevision

Device

Contact lens material: Balafilcon A

Other names: PV

Primary outcomes

  1. Lens Geometry

    Time frame: 1 week

Secondary outcomes

  1. Corneal Shape

    Time frame: 1 week

  2. Conjunctival Staining

    Time frame: 1 week

    The conjunctival staining

Sponsors and collaborators

Lead sponsor

Alcon Research

Industry

Registry information

Official study title

Changes in Invitro and ex Vivo Lens Metrology With Experienced Daily Wear Contact Lens Wearers

Important dates

Study start
2010
Primary completion
2010
Study completion
2010
First posted
Apr 9, 2010
Registry last updated
Jul 18, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.